top of page

The primary benefits of the Thermedical® Ablation System are summarized below:

 

 

 

Ventricular Tachycardia

 

  • Creates durable, transmural lesions that can potentially cure VT

 

  • Has the potential to reduce or eliminate the recurrence of VT by treating the underlying disease, not just the symptoms

 

  • Enables physicians to use standard, endocardial approach

 

  • Designed to result in a shorter, less complicated procedure which can increase safety

 

 

 

Soft Tissue Conditions

 

  • Can treat 5cm lesions with a single device

 

  • Has a predictable ablation zone

 

  • Creates well defined, symmetrical lesions with sharp transition between treated and untreated tissue

 

  • Designed to result in a shorter, less complicated procedure which can increase safety

Technology Platform

The Thermedical® Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.  Use of the Thermedical Ablation System for any specific soft tissue indication has not been evaluated or approved by the US FDA.

Use of the Thermedical Ablation System for the treatment of VT is investigational and is not approved for use or sale in any market.

150 Bear Hill Road,  Waltham, MA 02451-1036
781.373.3688

©Copyright Thermedical, Inc. 2011-2015. All Rights Reserved. | Copyright and Trademark Notice 
Thermedical® and Durablateâ„¢ are trademarks of Thermedical, Inc. registered in the United States and Internationally.

bottom of page